Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
Science 37's Metasite to Facilitate Phase 3 Study Enrollment byExpanding Access and Maximizing Convenience for PatientsRESEARCH TRIANGLE PARK, N.C., July 11, 2023 -- Science 37 Holdings, Inc....
Source: marketscreener.com